Pursuant to Regulation 34 of the SEBI (LODR) Regulations, 2015 as amended, we herewith submit the Annual Report of the Company for the financial year 2025-2026 along with the Notice convening ....

C~ENTENIAdiV ISO ISO iso 1 iso IW-H.O.I (( AL SUTURE LTD 9001 ,2015 13485:2016 14001:2015l45001,20181 G.M'P. I SURe I Regd.OFFice , F-29, MIDC, September 1, 2026 Department of Corporate Service BSE limited, Registered Office : Floor 25, P. J. Towers, Dala1 Street, Fort, Mumbai 400001. MAHARASHTRA. T: 2272 1233 / 1234 1 F : 2272 3121 / 3719 [ www.bseindia.com Subject : Submisgon of 31“ Annual Report for the Financial Year 2025 - 2026 pursuant to Compliance as per Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements [LODR]) Regulations, 2015. Reference : CENTENIAL SURGICAL SUTURE LTD. I Scrip Code: 531380 Sir, Pursuant to Regulation 34 of the SEBI (LODR) Regulations, 2015 as amended, we herewith submit the Annual Report of the Company for the 6nancial year 2025-2026 along with the Notice convening the 31“ Annual General Meeting which will be held on Monday, September 28, 2026 through Video Conferencing (“VC”) / Other Audio-Visual Means (“OAVM”). The Annual Report is also available on our website at the link: www.centenialindia.com/corporate This is for your information and record. Sincerely, For C] SURGICAL SUTURE LTD. Mah ima PJ?iTJllisi?FytIEra Bathwal PJbei,3:2+68T;cal Mahima BATHWAL Membership No. : ACS 35069 'ompany Secretary & Compliance O£6ber • Registered Office • ManufacturingF acility • Sales Office - Mumbai Sales Office - Kolkata F-29. MIDC, Murbad. Thane 421401 B-17 / F-29 / F-22 / 23 MIDC. Murbad. 1 ’ Floor, Palai Complex CHS Ltd. Flat No. N-1. Ground Floor. 385. MAHARASFrrRA. Thane 421401. MAHARASHTRA. Bhandarkar Road. Matunga (East), Purbachal, Kalitala Road. P.S.Kasba. C912524222 W5 Fax q2a4161261 C 912524223203 Fax 912224161261 Mumbai 400019. MAHARASHTRA Kolkata 700078. WEST BENGAL C912224102976F ax 912224161261 C91 33248++875 Faxq 33248#875 E N T E N I A L S U R G I C A L S U T U R E L T D. 31st Annual Report 2025 ~ 2026 moc.aidnilainetnec.www ynapmoc deifitrec PMG-OHW 8102:10054 6102 58431 1009 CORPORATE INFORMATION BOARD OF DIRECTORS (as on August 14, 2026) Vijay MAJREKAR (DIN: 00804808) Managing Director / Chief Executive Officer Anuradha KASHIKAR (DIN: 00804831) Executive Director Devraj T. POOJARY (DIN: 02041726) Executive Director Neel M. VORA (DIN: 07699873) Independent Non-Executive Director Ridhima B. LIMAYE (DIN: 10256393) Independent Non-Executive Director Akash S. MODI (DIN: 08698016) Independent Non-Executive Director Anuj V. SHAH (DIN: 10256390) Independent Non-Executive Director S. MHATRE Chief Financial Officer J. RATHOD Chief Operating Officer M. BATHWAL (Membership No. ACS A35069) Company Secretary and Compliance Officer BANKERS Canara Bank Ltd. REGISTERED OFFICE F-29, MIDC, Murbad, Thane 421401. Maharashtra. MANUFACTURING FACILITIES & SITE F-29 ; B-17 ; F-22 ; F-23 ; F-24 ; MIDC, Murbad, Thane 421401. Maharashtra. Village Dhavale, Ambernath, Thane, Maharashtra. AUDITORS Mahesh Chandra & Associates SECRETARIAL AUDITORS HSPN & Associates LLP REGISTRARS & SHARE TRANSFER AGENTS Purva Sharegistry (India) Pvt. Ltd. SEBI registration no.: INR000001112. Forward-looking Information In this Annual Report we have disclosed forward - looking information to enable investors to comprehend our prospects & take informed investment decisions. This report & other statements – written that we periodically make contain forward-looking statements that set out anticipated results based on the management’s plans & assumptions. We have tried wherever possible to identify such statements by using words such as anticipated, estimates, expects, projects, intends, plans believes & words of similar substance in connection with any discussion of future performance. We cannot guarantee that these forward-looking statements will be realized, although we believe we have been prudent in assumptions. The achievement of results is subject to ri sks, uncertainties & even inaccurate assumptions. Should known or unknown risks or uncertainties materialize or should underlying assumptions prove in accurate, actual results could vary materially from anticipated, estimated or projected. Readers should bear this in mind. The information & opinions c ontained in this report do not constitute an offer to buy any of Company’s securities, businesses, products or services. The report also contains forward- looking statements, qualified in connection with any discussion of future performance that we believe to be true at the time of the preparation of the report. The Company does not take on any obligation to publicly update any forward- looking statement, whether as a result of new information, future events or otherwise. DIRECTORS’ REPORT Dear Shareholders, The 31st Annual Report of the Company together with the audited financial statements of the Company for the year ended March 31, 2026. 1. Operating Results The operating results of the Company for the year ended March 31, 2026 : Rs. in Lakhs For the year ended March 31 2026 2025 Net Profit before Depreciation & Taxation 191.56 294.51 Less : Depreciation 399.88 425.46 Provision for Deferred Taxation 10.42 15.41 Provision for Taxation / Written Off 22.54 - Net Profit/(Loss) (220.46) (146.37) Add : Balance from Last Year 2533.06 2679.41 Prior Period Profit adjustments - - Less : Appropriation - - Transfer to Reserves Profit / (Loss) carried to Balance Sheet 2312.60 2533.06 Despite the challenging global economic landscape, CENTENIAL has remained resilient, adaptable, and focused on our strategic objectives. This steadfast dedication has enabled us to navigate through uncertainties and emerge even stronger. In this challenging business environment, we unfortunately were behind the projected pace for achieving our target for 2025 – 2026 and having acknowledged this reality head-on, the business environment was significantly impacted by shifts in market dynamics due to oversupply and intensifying competition from the emerging new companies in the rest of our country and prices in the suture industry. We do expect these difficulties to persist long-term. However, we are making steady progress in reducing our input costs by manufacturing suture materials and raw materials for the atraumatic needle sutures, is bringing us closer to our ideal vision. With a strong commitment to accelerating this momentum and putting our business back on a growth trajectory, we remain determined to achieve our target of operating income for the year 2026 - 2027. Life saving medical devices like sterile atraumatic needled sutures industry where there is zero margin for error, and in the sterile atraumatic needled sutures segment, surgical operational reliability is the ultimate differentiator. At CENTENIAL, our decades-long journey brings this perspective to the fore while encapsulating our belief that sustainable market leadership is achieved through QUALITY that remains unshakable and capabilities that never stop evolving. All along our journey, we have maintained a solid foundation of QUALITY EXCELLENCE, manufacturing world class sterile atraumatic needled sutures and regulatory compliance that protects patients health across markets. This disciplined framework allows CENTENIAL to scale operations without sacrificing the consistency necessitated by CDSCO, USP, we ensure the seamless delivery of safe sterile atraumatic needled sutures that lead the marketplace with our benchmark QUALITY. The Quality and Safety of our medical devices / products are critical to our business and the CENTENIAL’s reputation of its brands, form the foundation of our relationships with SURGEONS and suppliers. Many of our brands have country wide recognition and our financial success is directly dependent on the success of our brands. The success of our brands can suffer if our marketing and advertising plans or product initiatives do not have the desired impact on a brand’s image or its ability to attract confidence in our SURGEONS. The suture market environment is highly competitive with international, regional and local competitors [Showing first 8,000 characters — download PDF for full document]